A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
暂无分享，去创建一个
M. Schlumberger | D. Ball | B. Jarzab | L. Licitra | S. Sherman | R. Elisei | F. Pacini | M. Shah | K. Newbold | L. Burmeister | B. Robinson | Y. Funahashi | M. Ren | R. Martins | J. Mccaffrey | M. Cabanillas | D. Bodenner | J. O'brien | R. Allison | M. Shah